Parkinson's disease can affect thinking as well as movement, and dementia may develop gradually as the disease progresses. Parkinson's disease dementia is part of Lewy body dementia, a group of conditions that can affect memory, attention, movement, behavior, mood, and automatic body functions. Cognitive changes do not automatically mean dementia. Mild changes may leave daily activities intact, while dementia causes lasting problems that interfere with everyday life.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What is the difference between Parkinson's dementia and Lewy body dementia?
- What changes should families look for?
- How common is dementia in Parkinson's disease?
- How is Parkinson's-related dementia diagnosed?
- Is there treatment for Parkinson's disease dementia?
What is the difference between Parkinson's dementia and Lewy body dementia?
Lewy body dementia is the umbrella term for two related diagnoses: Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB). Both involve abnormal alpha-synuclein deposits, called Lewy bodies.
The timing of cognitive decline helps clinicians distinguish them. PDD is diagnosed when substantial cognitive decline begins more than one year after Parkinsonian movement symptoms. DLB is diagnosed when cognitive problems come first or begin around the same time as movement symptoms, according to the National Institute on Aging's Lewy body dementia guidance.
What changes should families look for?
Changes can include poorer attention, planning, judgment, problem-solving, and visual-spatial skills, such as judging distance or navigating familiar spaces. In DLB, these difficulties may stand out before major memory loss. Other common DLB features include attention that varies noticeably from one period to another, visual hallucinations, REM sleep behavior disorder, and Parkinsonian movement symptoms.
The National Institute on Aging describes this combination as a key reason DLB can look different from Alzheimer's disease. A sudden change deserves prompt attention. Parkinson's-related dementia usually develops gradually, so abrupt confusion may point to infection, medication effects, sleep problems, or a mood disorder, according to the Parkinson's Foundation.
How common is dementia in Parkinson's disease?
Not everyone with Parkinson's disease develops dementia. Cognitive impairment exists on a range, from mild changes that do not disrupt day-to-day life to dementia that permanently affects independent living.
The Parkinson's Foundation reports that up to 70% of people with Parkinson's may develop dementia during disease progression. That figure is useful for planning, but it does not predict what will happen to one individual or when cognitive changes may begin. Parkinson's Foundation dementia information.
How is Parkinson's-related dementia diagnosed?
Clinicians use a detailed history, neurological examination, cognitive assessment, and tests to rule out other explanations. There is no single scan or medical test that definitively diagnoses Lewy body dementia during life.
Early symptoms can be mistaken for Alzheimer's disease or psychiatric illness. A clear diagnosis helps the care team tailor treatment to symptoms and helps families plan for support, driving, medication management, legal documents, and finances. National Institute on Aging guidance.
Is there treatment for Parkinson's disease dementia?
Treatment can address symptoms, but it does not cure the disease. Rivastigmine is FDA-indicated for mild-to-moderate dementia associated with Parkinson's disease.
Rivastigmine can cause nausea, vomiting, diarrhea, reduced appetite, weight loss, and dizziness. A person taking it should report side effects that affect eating, weight, balance, or daily functioning to the prescribing clinician; see the FDA-approved Exelon Patch label.
You Might Also Like
- Safety Questions After the 2026 LiBBY Dementia Trial: What the Findings Mean for Family Caregivers
- LiBBY Trial Findings for Late-Stage Dementia Agitation in 2026: What the Findings Mean for Family Caregivers
- Aphasia for Dementia Care 2026 Guide: safety, access, and evidence limits; Key Facts and Questions to Ask
